Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Association of ADAMTS13 Activity with Gender in Normal Adult Cohort

Despoina Adamidou, MD, Erasmia Rouka, Evgenia Verrou, MD, Giannis Koutsaliaris, Anna Lazaridou, MD, Despoina Kyriakou, MD, Phd

Blood (2008) 112 (11): 4554.

https://doi.org/10.1182/blood.V112.11.4554.4554

Published: 2008

Journal Articles

Differente Patterns of Telomerase Reverse Transcriptase (hTERT) mRNA Variant Expression Profiles in Patients with Myelodysplastic Syndromes (MDS) and Acute Myelogenous Leukemia (AML)

Evgenia Verrou, MD, Vassiliki Kaloutsi, MD, Phd, Eirini Katodritou, MD, Phd, Vasilia Garypidou, MD, Phd, Anna Nikitidou, Vassiliki Gastari, MD, Anna Lazaridou, MD, Phd, Konstantinos Zervas, MD, Phd, Vassiliki Kotoula, MD, Phd

Blood (2008) 112 (11): 4483.

https://doi.org/10.1182/blood.V112.11.4483.4483

Published: 2008

Journal Articles

The Addition of Thalidomide in Any Line of Treatment of Multiple Myeloma, Improves Overall Survival: Single Center Experience in 246 Patients.

Eirini Katodritou, MD, PhD, Evgenia Verrou, MD, Anastasia Banti, MD, Vassiliki Gastari, MD, Dimitra Mihou, MD, Christina Hadjiaggelidou, MD, Dimitra Markala, MD, Anna Lazaridou, MD, PhD, Evangelos Terpos, MD, PhD, Konstantinos Zervas, MD, PhD

Blood (2007) 110 (11): 4813.

https://doi.org/10.1182/blood.V110.11.4813.4813

Published: 2007

Journal Articles

Recombinant Human Erythropoietin May Negatively Influence Survival in Newly Diagnosed Patients with Multiple Myeloma: A Single Center Experience in 246 Patients.

Blood (2007) 110 (11): 4814.

https://doi.org/10.1182/blood.V110.11.4814.4814

Published: 2007

Journal Articles

Thalidomide–Containing Regimens Induce Recovery of Normal Immunoglobulins in Newly Diagnosed Patients with Multiple Myeloma; Recovery of Normal Immunoglobulins Improves Survival.

Eirini Katodritou, MD, PhD, Evgenia Verrou, MD, Anastasia Banti, MD, Dimitra Mihou, MD, Vassiliki Gastari, MD, Christina Hadjiaggelidou, MD, Dimitra Markala, MD, Anna Lazaridou, MD, PhD, Evangelos Terpos, MD, PhD, Konstantinos Zervas, MD, PhD

Blood (2007) 110 (11): 2738.

https://doi.org/10.1182/blood.V110.11.2738.2738

Published: 2007

NARROW

Association of ADAMTS13 Activity with Gender in Normal Adult Cohort

Differente Patterns of Telomerase Reverse Transcriptase (hTERT) mRNA Variant Expression Profiles in Patients with Myelodysplastic Syndromes (MDS) and Acute Myelogenous Leukemia (AML)

The Addition of Thalidomide in Any Line of Treatment of Multiple Myeloma, Improves Overall Survival: Single Center Experience in 246 Patients.

Recombinant Human Erythropoietin May Negatively Influence Survival in Newly Diagnosed Patients with Multiple Myeloma: A Single Center Experience in 246 Patients.

Thalidomide–Containing Regimens Induce Recovery of Normal Immunoglobulins in Newly Diagnosed Patients with Multiple Myeloma; Recovery of Normal Immunoglobulins Improves Survival.

Email alerts

ASH Publications

American Society of Hematology

Association of ADAMTS13 Activity with Gender in Normal Adult Cohort

Differente Patterns of Telomerase Reverse Transcriptase (hTERT) mRNA Variant Expression Profiles in Patients with Myelodysplastic Syndromes (MDS) and Acute Myelogenous Leukemia (AML)

The Addition of Thalidomide in Any Line of Treatment of Multiple Myeloma, Improves Overall Survival: Single Center Experience in 246 Patients.

Recombinant Human Erythropoietin May Negatively Influence Survival in Newly Diagnosed Patients with Multiple Myeloma: A Single Center Experience in 246 Patients.

Thalidomide–Containing Regimens Induce Recovery of Normal Immunoglobulins in Newly Diagnosed Patients with Multiple Myeloma; Recovery of Normal Immunoglobulins Improves Survival.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only